Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Completed

• Conditions: Neoplasms, Colorectal; Diagnosis; General Practitioner; Pandemic, COVID-19; Neoplasm, Liver; Neoplasms Pancreatic; Advanced Cancer

• Registration Number: NCT06118125
• Lead Sponsor: University of Bordeaux

Brief Summary

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Detailed Description

Method: patient records discussed in Digestive Oncology CPR of Bordeaux University Hospital for the first time from June 1 to August 31, 2020 and over the same period in 2019 were included. A questionnaire on the dates of the first symptoms, first consultation with the general practitioner, imaging examination and access to the specialist was sent to the general practitioner. The primary outcome was time from onset to date of first MDT.

Study Timeline

• Study Start: 2019-06-01
• Primary Completion: 2022-09-01
• Study Completion: 2022-09-01
• Study First Submitted: 2023-10-25
• Status Verified: 2023-11
• Study First Submitted QC: 2023-11-01
• Last Update Submitted: 2023-11-01
• Study First Posted: 2023-11-07
• Last Update Posted: 2023-11-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 376

Inclusion Criteria

• residing in New Aquitaine and
• whose general practitioner practiced in New Aquitaine
• malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
• to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

Exclusion Criteria

• Patients under 18 years of age,
• who had already had a MDT for this cancer,
• whose date of first MDT was outside the inclusion dates,
• whose new cancer was a digestive metastasis of a primary of another location,
• who did not have French health insurance

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
time from date of first symptoms of cancer to the date of first MDT	DAYS	time from date of first symptoms of cancer to the date of first MDT

Secondary Outcome Measures

Name	Time	Method
time from date of first symptoms to date of first consultation with a general practitioner,	DAYS	time from date of first symptoms to date of first consultation with a general practitioner,
time from date of first symptoms to first imaging or specific examination,	DAYS	difficulties in referral to imaging,
stage of pathology by type of cancer,	at inclusion	stage of pathology by type of cancer according to TNM classification (tumor, node, metastatic status)
time from date of first symptoms to consultation with a specialist,	DAYS	difficulties in referral to a specialist,
frequency of different types of cancer,	at inclusion	PERCENTAGE of each type of cancers in this study
overall survival.	MONTHS, time from from date of first symptoms to date of death	overall survival.

Trial Locations

Locations (1)

Blanc-Bisson Christele; 🇫🇷 Bordeaux, France